Kiyoshi Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kiyoshi Yoshida has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Nozomi Watanabe
12 shared publicationsTakashi Akasaka
10 shared publications- Yoji Neishi
Department of Cardiology, Kawasaki Medical School
10 shared publications Takahiro Kawamoto
9 shared publications- Teruyoshi Kume
Department of Cardiology Kawasaki Medical School Kurashiki Okayama Japan
9 shared publications - Hiroyuki Okura
Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
5 shared publications
Latest Publications
- 1 October 2016
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 9 (10)
Effect of Annuloplasty for Mitral Valve Prolapse
- 1 October 2016
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 9 (10)
Effect of Annuloplasty for Mitral Valve Prolapse
- 16 August 2016
- Published by Springer Nature in Journal of Echocardiography
- Vol. 14 (3) , 89-90
In memoriam: Junichi Yoshikawa, MD, PhD, 1941–2016
- 16 August 2016
- Published by Springer Nature in Journal of Echocardiography
- Vol. 14 (3) , 89-90
In memoriam: Junichi Yoshikawa, MD, PhD, 1941–2016
- 1 September 2015
- Vol. 24 (5) , 577-85
Prognostic Implication of Three-Dimensional Mitral Valve Tenting Geometry in Dilated Cardiomyopathy.
Functional mitral regurgitation (FMR) is a clinically important complication of left ventricular (LV) dysfunction, occurring as a result of geometric deformity in the mitral valve (MV) complex. The study aim was to determine whether tenting parameters derived from real-time three-dimensional echocardiography (RT3DE) can predict the long-term prognosis for patients with dilated cardiomyopathy (DCM). Mitral valve tenting morphology, LV volume and function, and papillary muscle positions were monitored using transthoracic RT3DE in 75 subjects (66 with DCM, nine controls). The maximum tenting sites of the leaflet (maxTS) were also mapped from the reconstructed 3D images, to determine if the 3D tenting parameters correlated to long-term outcome. Follow up information was collected from 62 patients with DCM over a mean period of 42 +/- 31 months. Cardiovascular events occurred in 30 patients (48%), including 13 cardiac deaths (21%). The patients were allocated to an Event group (n = 30) or a Non-event group (n = 32). The LV volumes were significantly larger and LV ejection fraction was lower in the Event group compared to the Non-event group. The 3D tenting volumes were significantly larger in the Event group than the Non- event group (p = 0.05). The maxTS were positioned mostly in the middle portion of the anterior mitral leaflet in the Non-event group (maxTS-mid AML), but in the Event group they were mostly found in the MV coaptation region of the leaflet (maxTS-coapt) (p <0.001). Patients with maxTS-coapt had a worse prognosis compared to those with maxTS-mid AML. On multivariate Cox regression analysis, maxTS was the strongest predictor of event-free survival. The 3D tenting pattern, assessed with RT3DE, would be an important clinical parameter in predicting long-term prognosis in patients with DCM.
- 1 September 2015
- Vol. 24 (5) , 577-85
Prognostic Implication of Three-Dimensional Mitral Valve Tenting Geometry in Dilated Cardiomyopathy.
Functional mitral regurgitation (FMR) is a clinically important complication of left ventricular (LV) dysfunction, occurring as a result of geometric deformity in the mitral valve (MV) complex. The study aim was to determine whether tenting parameters derived from real-time three-dimensional echocardiography (RT3DE) can predict the long-term prognosis for patients with dilated cardiomyopathy (DCM). Mitral valve tenting morphology, LV volume and function, and papillary muscle positions were monitored using transthoracic RT3DE in 75 subjects (66 with DCM, nine controls). The maximum tenting sites of the leaflet (maxTS) were also mapped from the reconstructed 3D images, to determine if the 3D tenting parameters correlated to long-term outcome. Follow up information was collected from 62 patients with DCM over a mean period of 42 +/- 31 months. Cardiovascular events occurred in 30 patients (48%), including 13 cardiac deaths (21%). The patients were allocated to an Event group (n = 30) or a Non-event group (n = 32). The LV volumes were significantly larger and LV ejection fraction was lower in the Event group compared to the Non-event group. The 3D tenting volumes were significantly larger in the Event group than the Non- event group (p = 0.05). The maxTS were positioned mostly in the middle portion of the anterior mitral leaflet in the Non-event group (maxTS-mid AML), but in the Event group they were mostly found in the MV coaptation region of the leaflet (maxTS-coapt) (p <0.001). Patients with maxTS-coapt had a worse prognosis compared to those with maxTS-mid AML. On multivariate Cox regression analysis, maxTS was the strongest predictor of event-free survival. The 3D tenting pattern, assessed with RT3DE, would be an important clinical parameter in predicting long-term prognosis in patients with DCM.
- 1 December 2013
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 9 (8) , 1008
A unique feature of thin flat thrombus visualised by optical coherence tomography
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 December 2013
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 9 (8) , 1008
A unique feature of thin flat thrombus visualised by optical coherence tomography
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 12 March 2013
- Published by Wiley in Echocardiography
- Vol. 30 (8) , 945-951
Visualization of Submitral Structure by Three-Dimensional Transesophageal Echocardiography
- 12 March 2013
- Published by Wiley in Echocardiography
- Vol. 30 (8) , 945-951
Visualization of Submitral Structure by Three-Dimensional Transesophageal Echocardiography
- Open Access
- 1 January 2012
- Published by Korean Society of Echocardiography in Journal of Cardiovascular Ultrasound
- Vol. 20 (2) , 69-76
Assessment of Mitral Valve Complex by Three-Dimensional Echocardiography: Therapeutic Strategy for Functional Mitral Regurgitation
Yoshida K, et al. J Cardiovasc Ultrasound. 2012 Jun;20(2):69-76. http://dx.doi.org/10.4250/jcu.2012.20.2.69
- 1 January 2012
- Published by Korean Society of Echocardiography in Journal of Cardiovascular Ultrasound
- Vol. 20 (2) , 69-76
Open AccessAssessment of Mitral Valve Complex by Three-Dimensional Echocardiography: Therapeutic Strategy for Functional Mitral Regurgitation
Yoshida K, et al. J Cardiovasc Ultrasound. 2012 Jun;20(2):69-76. http://dx.doi.org/10.4250/jcu.2012.20.2.69
- 1 September 2011
- p. 55-9
[Coronary flow reserve].
- Open Access
- 31 October 2008
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 136 (4) , 868-875
Chordal translocation for ischemic mitral regurgitation may ameliorate tethering of the posterior and anterior mitral leaflets
- 31 October 2008
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 136 (4) , 868-875
Open AccessChordal translocation for ischemic mitral regurgitation may ameliorate tethering of the posterior and anterior mitral leaflets
- 1 January 2008
- Vol. 17 (1) , 89-93
Mechanism of increasing systolic coronary flow velocity in patients with aortic regurgitation.
The mechanism of increasing systolic coronary flow velocity of the epicardial coronary artery in patients with aortic regurgitation (AR) has not been well investigated. Thus, an evaluation was made of the flow velocity pattern of the epicardial coronary artery in these patients. In 12 patients with AR, epicardial coronary flow velocity was monitored using Doppler guidewire, and diameter changes of the epicardial coronary artery using intravascular ultrasound (IVUS). The systolic coronary vascular resistance in AR patients was significantly less than that in controls (1.8 +/- 0.9 versus 3.3 +/- 0.7 mmHg/ml/min; p <0.01). Likewise, area and diameter changes of the epicardial coronary artery during the cardiac cycle in AR patients were significantly less than those in controls (102 +/- 1% versus 106 +/- 4%; p <0.01; and 102 +/- 1% versus 106 +/- 4%; p = 0.03). In patients with AR, the increase in systolic coronary flow velocity of the epicardial coronary artery during the systolic phase was considered to result from a major coronary perfusion of blood into the intramyocardial vessels (which showed a decreased resistance), rather than it being stored in the epicardial coronary artery.
- 1 January 2008
- Vol. 17 (1) , 89-93
Mechanism of increasing systolic coronary flow velocity in patients with aortic regurgitation.
The mechanism of increasing systolic coronary flow velocity of the epicardial coronary artery in patients with aortic regurgitation (AR) has not been well investigated. Thus, an evaluation was made of the flow velocity pattern of the epicardial coronary artery in these patients. In 12 patients with AR, epicardial coronary flow velocity was monitored using Doppler guidewire, and diameter changes of the epicardial coronary artery using intravascular ultrasound (IVUS). The systolic coronary vascular resistance in AR patients was significantly less than that in controls (1.8 +/- 0.9 versus 3.3 +/- 0.7 mmHg/ml/min; p <0.01). Likewise, area and diameter changes of the epicardial coronary artery during the cardiac cycle in AR patients were significantly less than those in controls (102 +/- 1% versus 106 +/- 4%; p <0.01; and 102 +/- 1% versus 106 +/- 4%; p = 0.03). In patients with AR, the increase in systolic coronary flow velocity of the epicardial coronary artery during the systolic phase was considered to result from a major coronary perfusion of blood into the intramyocardial vessels (which showed a decreased resistance), rather than it being stored in the epicardial coronary artery.